THE ROLE OF HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMA PATHOGENESIS – A PROBLEM OF A MODERN MAN

THE ROLE OF HEPATITIS C VIRUS IN HEPATOCELLULAR CARCINOMA PATHOGENESIS – A PROBLEM OF A MODERN MAN

People with hepatitis C virus (HCV) have a 2% annual risk, and a 7% to 14% five-year risk for hepatocellular carcinoma development, a tumor with an estimated median survival of 4.3 to 20 months after making the diagnosis. HCV is the cause of: 20% of acute hepatitis, 70% of chronic hepatitis, 40% of...

Full description

Bibliographic Details
Main Authors:	Bojan Ilić, Milan Radojković, Milica Nestorović, Vanja Pecić
Format:	Article
Language:	English
Published:	University in Nis, Faculty of Medicine 2009-04-01
Series:	Acta Medica Medianae
Subjects:	hepatitis C virus hepatocellular carcinoma hepatocelularni karcinom
Online Access:	http://publisher.medfak.ni.ac.rs/2009-html/2-broj/THE%20ROLE%20OF%20HEPATITIS%20C%20....pdf

Similar Items

Association between hepatitis C and hepatocellular carcinoma
by: Luis Jesuino de Oliveira Andrade, et al.
Published: (2009-01-01)

Cure in Chronic Hepatitis C! Does it Prevent the Risk of Hepatocellular Carcinoma?
by: Mustafa Kemal ÇELEN, et al.
Published: (2018-06-01)

Sorafenib use in hepatitis B virus‐ or hepatitis C virus‐related hepatocellular carcinoma: A propensity score matching study
by: Yu‐Chi Lee, et al.
Published: (2021-10-01)

Hepatitis virus and hepatocellular carcinoma in Brazil: a report from the State of Espírito Santo
by: Patrícia Lofêgo Gonçalves, et al.
Published: (2014-10-01)

Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
by: Xinhe Zhang, et al.
Published: (2021-09-01)

Clinical significance of vascular endothelial growth factor in hepatitis C related hepatocellular carcinoma in Egyptian patients
by: Atta MM, et al.
Published: (2016-06-01)

Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study
by: Oh Jin-Kyoung, et al.
Published: (2012-10-01)

Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon
by: Naoki Hotta, et al.
Published: (2009-07-01)

Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review
by: Ottovon Bismark Dakurah, et al.
Published: (2021-06-01)

Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma
by: Hye Kyong Park, et al.
Published: (2019-08-01)

Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
by: Xiaofei Li, et al.
Published: (2020-04-01)

Comparison of the efficacy and safety of direct-acting antiviral therapy with or without hepatitis C-related hepatocellular carcinoma
by: Byung Soo Kwan, et al.
Published: (2021-03-01)

Viral Genotypes and Associated Risk Factors of Hepatocellular Carcinoma in India
by: Manash Pratim Sarma, et al.
Published: (2012-09-01)

A prominent role of Hepatitis D Virus in liver cancers documented in Central Africa
by: Marie Atsama Amougou, et al.
Published: (2016-11-01)

Aspirin Use and the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B Virus or Hepatitis C Virus Infection: A Meta-Analysis of Cohort Studies
by: Xiaofei Li, et al.
Published: (2021-01-01)

Incidence of Hepatocellular Carcinoma in Patients with Thalassemia Who Had Hepatitis C
by: Shahla Ansari, et al.
Published: (2013-06-01)

Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
by: Yen-Hsiang Liao, et al.
Published: (2020-01-01)

Low occurrence of occult hepatitis B virus infection and high frequency of hepatitis C virus genotype 3 in hepatocellular carcinoma in Brazil
by: R.S.M. Alencar, et al.
Published: (2008-03-01)

Characteristics and Survival Outcomes of Hepatocellular Carcinoma Developed after HCV SVR
by: Ming-Lun Yeh, et al.
Published: (2021-07-01)

Direct-acting antivirals response in hepatocellular carcinoma: Does the presence of hepatocellular carcinoma matter?
by: Chung-Feng Huang, et al.
Published: (2019-03-01)

Links between human LINE-1 retrotransposons and hepatitis virus-related hepatocellular carcinoma
by: Tomoyuki eHonda, et al.
Published: (2016-05-01)

Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma
by: Abdel-Rahman N. Zekri, et al.
Published: (2014-01-01)

Hepatitis C virus and hepatocarcinogenesis
by: Soung Won Jeong, et al.
Published: (2012-12-01)

Incidence of Hepatocellular Carcinoma in Patients with Thalassemia Who Had Hepatitis C
by: Shahla Ansari, et al.
Published: (2013-06-01)

Gut microbiome in cirrhotic hepatitis C virus patients with and without hepatocellular carcinoma
by: Khaled Mohieldeen, et al.
Published: (2021-09-01)

Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Dual Infection
Published: (2006-04-01)

Comparison of prognosis by viral etiology in patients with hepatocellular carcinoma after radiofrequency ablation
by: Ping-Hsien Chen, et al.
Published: (2013-03-01)

Performance study of the automated immunoassay test anti-hepatitis C virus VIDAS® for the qualitative detection of antibodies anti-hepatitis C virus
by: Sara Salvetti, et al.
Published: (2016-03-01)

Prior hepatitis B virus infection as a co-factor of chronic hepatitis C patient survival after resection of hepatocellular carcinoma
by: Yutaka Midorikawa, et al.
Published: (2019-08-01)

Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence
by: Nevine Ibrahim Musa, et al.
Published: (2020-07-01)

Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation
by: Liat Ninio, et al.
Published: (2019-11-01)

Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas
by: Yi-Wen Hsiao, et al.
Published: (2019-08-01)

Acute pulmonary embolism in a patient with hepatitis C virus infection and hepatocellular carcinoma: a case report
by: Mahmoud Abdelnabi, et al.
Published: (2021-07-01)

Immunological Mechanisms for Hepatocellular Carcinoma Risk after Direct-Acting Antiviral Treatment of Hepatitis C Virus Infection
by: Pil Soo Sung, et al.
Published: (2021-01-01)

Frequency and geographic distribution of TERT promoter mutations in primary hepatocellular carcinoma
by: Francesca Pezzuto, et al.
Published: (2017-05-01)

Potential risk factors for the reactivation of the replication of hepatitis B and C viruses after transcatheter arterial chemoembolization of hepatocellular carcinoma
by: Chia-I. Lin, et al.
Published: (2011-12-01)

Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis
by: Antoine Finianos, et al.
Published: (2018-12-01)

Diagnostic significance of plasma osteopontin in hepatitis C virus-related hepatocellular carcinoma
by: Mona A. Abu El Makarem, Prof., et al.
Published: (2011-07-01)

Potential Susceptibility Mutations in C Gene for Hepatitis B-Related Hepatocellular Carcinoma Identified by a Two-Stage Study in Qidong, China
by: Lishuai Qu, et al.
Published: (2016-10-01)

Telaprevir-containing regimen for treatment of hepatitis C virus infection in patients with hepatocellular carcinoma awaiting liver transplantation: a case series
by: Torres HA, et al.
Published: (2014-07-01)

Cannot write session to /tmp/vufind_sessions/sess_b1cd8ki06m2fkak5k6fjrug79v